mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
-0.36 |
0.04 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |